HSPA5 and cancer: Small molecule and RNAi inhibitors capable of suppressing GRP78 expression or activity have recently been identified and reported to lower survival and alleviate drug and radio resistance in a wide variety of cancer cells5, 27, 46, 47, 48, 49.